19:50 IST
NSE
Acquisition
Cohance Lifesciences Acquisition Worth ₹169.2 Cr
Cohance Lifesciences announced a $18 million investment across two subsidiaries, NJ Bio and Aruka Bio, to strengthen its ADC strategy and commercial integration.
- Value
- ₹169.2 Cr